390 related articles for article (PubMed ID: 23539444)
21. Knockdown of prolyl-4-hydroxylase domain 2 inhibits tumor growth of human breast cancer MDA-MB-231 cells by affecting TGF-β1 processing.
Wottawa M; Leisering P; Ahlen Mv; Schnelle M; Vogel S; Malz C; Bordoli MR; Camenisch G; Hesse A; Napp J; Alves F; Kristiansen G; Farhat K; Katschinski DM
Int J Cancer; 2013 Jun; 132(12):2787-98. PubMed ID: 23225569
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling of the hypoxia signaling pathway in hypoxia-inducible factor 1alpha null mouse embryonic fibroblasts.
Vengellur A; Woods BG; Ryan HE; Johnson RS; LaPres JJ
Gene Expr; 2003; 11(3-4):181-97. PubMed ID: 14686790
[TBL] [Abstract][Full Text] [Related]
23. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
24. Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
Schlemminger I; Mole DR; McNeill LA; Dhanda A; Hewitson KS; Tian YM; Ratcliffe PJ; Pugh CW; Schofield CJ
Bioorg Med Chem Lett; 2003 Apr; 13(8):1451-4. PubMed ID: 12668010
[TBL] [Abstract][Full Text] [Related]
25. Effects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions.
Floyd ZE; Kilroy G; Wu X; Gimble JM
J Cell Biochem; 2007 Aug; 101(6):1545-57. PubMed ID: 17370314
[TBL] [Abstract][Full Text] [Related]
26. Collagen Prolyl Hydroxylases Are Bifunctional Growth Regulators in Melanoma.
Atkinson A; Renziehausen A; Wang H; Lo Nigro C; Lattanzio L; Merlano M; Rao B; Weir L; Evans A; Matin R; Harwood C; Szlosarek P; Pickering JG; Fleming C; Sim VR; Li S; Vasta JT; Raines RT; Boniol M; Thompson A; Proby C; Crook T; Syed N
J Invest Dermatol; 2019 May; 139(5):1118-1126. PubMed ID: 30452903
[TBL] [Abstract][Full Text] [Related]
27. The prolyl 4-hydroxylase inhibitor ethyl-3,4-dihydroxybenzoate generates effective iron deficiency in cultured cells.
Wang J; Buss JL; Chen G; Ponka P; Pantopoulos K
FEBS Lett; 2002 Oct; 529(2-3):309-12. PubMed ID: 12372619
[TBL] [Abstract][Full Text] [Related]
28. Significance of prolyl hydroxylase 2 in the interference of aryl hydrocarbon receptor and hypoxia-inducible factor-1 alpha signaling.
Seifert A; Katschinski DM; Tonack S; Fischer B; Navarrete Santos A
Chem Res Toxicol; 2008 Feb; 21(2):341-8. PubMed ID: 18072750
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGFβ.
Klotzsche-von Ameln A; Muschter A; Mamlouk S; Kalucka J; Prade I; Franke K; Rezaei M; Poitz DM; Breier G; Wielockx B
Cancer Res; 2011 May; 71(9):3306-16. PubMed ID: 21436457
[TBL] [Abstract][Full Text] [Related]
30. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases.
Koivunen P; Hirsilä M; Günzler V; Kivirikko KI; Myllyharju J
J Biol Chem; 2004 Mar; 279(11):9899-904. PubMed ID: 14701857
[TBL] [Abstract][Full Text] [Related]
31. Oxygen tension regulates the expression of a group of procollagen hydroxylases.
Hofbauer KH; Gess B; Lohaus C; Meyer HE; Katschinski D; Kurtz A
Eur J Biochem; 2003 Nov; 270(22):4515-22. PubMed ID: 14622280
[TBL] [Abstract][Full Text] [Related]
32. Biophytum sensitivum (L.) DC inhibits tumor cell invasion and metastasis through a mechanism involving regulation of MMPs, prolyl hydroxylase, lysyl oxidase, nm23, ERK-1, ERK-2, STAT-1, and proinflammatory cytokine gene expression in metastatic lung tissue.
Guruvayoorappan C; Kuttan G
Integr Cancer Ther; 2008 Mar; 7(1):42-50. PubMed ID: 18292594
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
Flashman E; Hoffart LM; Hamed RB; Bollinger JM; Krebs C; Schofield CJ
FEBS J; 2010 Oct; 277(19):4089-99. PubMed ID: 20840591
[TBL] [Abstract][Full Text] [Related]
34. Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1.
To KK; Huang LE
J Biol Chem; 2005 Nov; 280(45):38102-7. PubMed ID: 16157596
[TBL] [Abstract][Full Text] [Related]
35. Inappropriate production of collagen and prolyl hydroxylase by human breast cancer cells in vivo.
Al-Adnani MS; Kirrane JA; McGee JO
Br J Cancer; 1975 Jun; 31(6):653-60. PubMed ID: 169865
[TBL] [Abstract][Full Text] [Related]
36. HIF1α is a central regulator of collagen hydroxylation and secretion under hypoxia during bone development.
Bentovim L; Amarilio R; Zelzer E
Development; 2012 Dec; 139(23):4473-83. PubMed ID: 23095889
[TBL] [Abstract][Full Text] [Related]
37. Regulation of collagen prolyl 4-hydroxylase and matrix metalloproteinases in fibrosarcoma cells by hypoxia.
Fähling M; Perlewitz A; Doller A; Thiele BJ
Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):119-26. PubMed ID: 15556073
[TBL] [Abstract][Full Text] [Related]
38. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.
Kasiganesan H; Sridharan V; Wright G
Acta Physiol (Oxf); 2007 Jun; 190(2):163-9. PubMed ID: 17394573
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer cells rely on environmental pyruvate to shape the metastatic niche.
Elia I; Rossi M; Stegen S; Broekaert D; Doglioni G; van Gorsel M; Boon R; Escalona-Noguero C; Torrekens S; Verfaillie C; Verbeken E; Carmeliet G; Fendt SM
Nature; 2019 Apr; 568(7750):117-121. PubMed ID: 30814728
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of hypoxia-inducible factor-targeting prolyl hydroxylase domain-containing protein 2 (PHD2) enhances matrix synthesis by human chondrocytes.
Thoms BL; Murphy CL
J Biol Chem; 2010 Jul; 285(27):20472-80. PubMed ID: 20404338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
